These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7050180)

  • 41. Acute haemodynamic effects of oral prenalterol in severe heart failure.
    Petch MC; Wisbey C; Ormerod O; Scott C; Goodfellow RM
    Br Heart J; 1984 Jul; 52(1):49-52. PubMed ID: 6146324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hemodynamic actions of prenalterol in left ventricular failure.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic and myocardial metabolic effects of the beta-agonist prenalterol in ischemic left ventricular dysfunction.
    Kirlin PC; Walton JA; Brymer JF; Beauman G; Pitt B
    J Cardiovasc Pharmacol; 1984; 6(5):852-8. PubMed ID: 6209491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
    Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
    Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
    Klein W; Brandt D; Maurer E
    Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of long-term beta receptor stimulation with prenalterol on intrinsic heart rate in rats.
    Nylander E; Dahlström U
    Eur J Appl Physiol Occup Physiol; 1984; 53(1):48-52. PubMed ID: 6150847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Beta-adrenergic stimulation with prenalterol in sick sinus syndrome].
    Treese N; Russ M; Kasper W; Meinertz T; Pop T
    Z Kardiol; 1983 Aug; 72(8):481-6. PubMed ID: 6624189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inotropic, chronotropic and dromotropic effects of prenalterol, a new cardiostimulant drug.
    Moore EN; Aberg G; Spear JF; Hodess AB; Herrmann I; Adler G
    Acta Med Scand Suppl; 1982; 659():53-70. PubMed ID: 6958179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
    Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
    Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A; Klein G; Bibra HV; Sauer E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Circulatory effects of prenalterol (a selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
    Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Ging LQ; Guazzi M
    Cardiologia; 1982; 27(1):99-101. PubMed ID: 6152733
    [No Abstract]   [Full Text] [Related]  

  • 52. Inotropic drugs and their mechanisms of action.
    Scholz H
    J Am Coll Cardiol; 1984 Aug; 4(2):389-97. PubMed ID: 6330195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
    Tydén H; Johansson L; Nyström SO
    Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of prenalterol and volume loading with dextran on haemodynamics and oxygen consumption in dogs during high epidural block with special reference to the splanchnic region.
    Greitz T; Andreen M; Irestedt L
    Acta Anaesthesiol Scand; 1985 Jan; 29(1):37-44. PubMed ID: 2579516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Newer inotropic agents.
    Sharpe DN
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):215-8. PubMed ID: 6087050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemodynamic and cardiometabolic effects of prenalterol in patients with gram negative septic shock.
    Reiz S; Friedman A
    Acta Anaesthesiol Scand; 1980; 24(1):5-10. PubMed ID: 7376804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selectivity of prenalterol for adrenergic receptor subtypes: a potential mechanism of inotropic selectivity.
    Williams RS
    J Cardiovasc Pharmacol; 1983; 5(2):266-71. PubMed ID: 6188901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
    Shiu MF; Ireland MA; Littler WA
    Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of prenalterol and its N-homoveratryl derivative in the anaesthetized cat.
    Maccarrone C; Malta E; Raper C
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):245-50. PubMed ID: 6621718
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetic studies in man of the selective beta 1-adrenoceptor agonist, prenalterol.
    Graffner C; Hoffmann KJ; Johnsson G; Lundborg P; Rönn O
    Eur J Clin Pharmacol; 1981; 20(2):91-7. PubMed ID: 6114866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.